 BEVERLY, Mass., May 11, 2021 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the hiring of four additional sales representatives, including three for the veterinary market and one for the contract drug manufacturing market. 